-
Antimicrobial Resistance
- Given the success of control measures like vaccination, what prudent antibiotic stewardship strategies should the poultry sector prioritize in 2025 and beyond? Should there be greater public transparency and reporting on the use of antibiotics in laying hen flocks, and how can the industry ensure that managing this health risk doesn’t inadvertently lead to an AMR crisis?
-
15 Replies
-
The poultry sector strict antibiotic Stewardship priority should be more on Biosecurity, Vaccination and preventive health programs rather than routine antibiotics administration.
-
Exactly! Prudent management priorities should include prioritizing prevention over treatment, strong veterinary oversight, and not automatically penalizing producers who report disease and treat it appropriately.
Reducing antibiotic use without reducing disease merely shifts the problem.
-
Given how effective vaccines have been in preventing bacterial infections like Salmonella and E. coli in poultry, it’s important for the industry to start shifting away from routine, blanket use of antibiotics. Instead, the focus should be on targeted treatments guided by veterinarians, supported by strong biosecurity measures. This approach will play a key role in addressing antimicrobial resistance (AMR) as we move into 2025.
-
-
bio security
-
Good question. Smart antibiotic use & transparent reporting are key to keeping birds healthy while preventing AMR.
-
Excellent question. Vaccination and improved husbandry have reduced many infectious pressures, but prudent antimicrobial stewardship remains essential to prevent AMR backsliding. Here are concrete priorities the industry should focus on now and through 2025+:
<strong data-start=”454″ data-end=”527″>1) Make veterinary oversight and treatment guidelines non-negotiable.<br data-start=”527″ data-end=”530″> Ensure all antibiotic treatments are done under a vet-approved protocol (indication, drug choice, dose, duration) and follow international classifications (restrict or eliminate Highest-Priority Critically Important Antibiotics for routine use). This reduces misuse and preserves human-critical drugs. PMC+1
<strong data-start=”871″ data-end=”951″>2) Transparent, routine farm-level reporting with public summary statistics.<br data-start=”951″ data-end=”954″> Collect standardised metrics (mg active ingredient/kg biomass, treatments per 1,000 bird-days, % flocks treated, and % use of HPCIAs). Publish anonymised national/sector dashboards and year-on-year trends while protecting commercially sensitive details. Transparency builds trust and enables benchmarking. Open Knowledge FAO+1
<strong data-start=”1299″ data-end=”1357″>3) Link reduction targets to welfare-based safeguards.<br data-start=”1357″ data-end=”1360″> Set realistic, species-specific targets (as done in the UK/Netherlands), but combine them with welfare indicators (mortality, culling rates, clinical scores). This avoids perverse outcomes where producers stop necessary treatment to hit targets. Allow exception pathways for high-risk outbreaks with veterinary justification and reporting. British Poultry+1
<strong data-start=”1739″ data-end=”1830″>4) Scale up surveillance — pathogens, resistance, and antibiotic-use data (One Health).<br data-start=”1830″ data-end=”1833″> Integrate AMR testing from clinical isolates, farm environments (litter, water), and slaughter/egg testing with antibiotic-use data to spot trends and emerging resistance early. Share summaries with public health and regulatory bodies. Open Knowledge FAO+1
<strong data-start=”2108″ data-end=”2165″>5) Invest in prevention so antibiotics aren’t needed.<br data-start=”2165″ data-end=”2168″> Prioritise proven non-pharmaceutical measures: vaccination programmes, robust biosecurity, improved housing/stocking density, nutrition and management (including humidity/ventilation), and targeted use of alternatives (probiotics, phytogenics, competitive exclusion). These reduce disease incidence and antibiotic demand. PMC+1
<strong data-start=”2529″ data-end=”2595″>6) Rapid diagnostics and better record-keeping at flock level.<br data-start=”2595″ data-end=”2598″> Support field-usable diagnostics and digital record systems so decisions are evidence-based (not empirical mass medication). Records enable audits, benchmarking and more precise stewardship. QS+1
<strong data-start=”2828″ data-end=”2902″>7) Industry accountability: corporate procurement & retailer policies.<br data-start=”2902″ data-end=”2905″> Retailers and integrators should require stewardship plans from suppliers (targets, reporting, veterinary oversight) and reward good performers — while giving technical support to lagging farms. Public retailer reports (like supermarket antibiotic reports) accelerate progress. Tesco+1
<strong data-start=”3222″ data-end=”3266″>8) Communication & farmer/vet education.<br data-start=”3266″ data-end=”3269″> Continuous training on AMR risks, appropriate drug choices, withdrawal times, and alternatives is vital. Frame stewardship as preserving both market access and bird health, not just regulatory burden. PMC
<strong data-start=”3509″ data-end=”3574″>How to avoid inadvertently causing an AMR <em data-start=”3553″ data-end=”3557″>or welfare crisis
<ul data-start=”3575″ data-end=”4090″>
Avoid blunt, year-end bans that remove therapeutic options without alternative disease control — phase changes with technical support.
Use outcome-based monitoring (mortality, disease incidence) alongside antibiotic metrics to ensure welfare isn’t compromised.
Maintain a clear, documented therapeutic pathway for emergencies that is audited afterwards.
Invest in environmental controls and waste management — reducing ARG spread in litter and runoff is critical. PMC+1Excellent question. Vaccination and improved husbandry have reduced many infectious pressures, but prudent antimicrobial stewardship remains essential to prevent AMR backsliding. Here are concrete priorities the industry should focus on now and through 2025+:
1) Make veterinary oversight and treatment guidelines non-negotiable.
Ensure all antibiotic treatments are done under a vet-approved protocol (indication, drug choice, dose, duration) and follow international classifications (restrict or eliminate Highest-Priority Critically Important Antibiotics for routine use). This reduces misuse and preserves human-critical drugs.
PMC
+12) Transparent, routine farm-level reporting with public summary statistics.
Collect standardised metrics (mg active ingredient/kg biomass, treatments per 1,000 bird-days, % flocks treated, and % use of HPCIAs). Publish anonymised national/sector dashboards and year-on-year trends while protecting commercially sensitive details. Transparency builds trust and enables benchmarking.
Open Knowledge FAO
+13) Link reduction targets to welfare-based safeguards.
Set realistic, species-specific targets (as done in the UK/Netherlands), but combine them with welfare indicators (mortality, culling rates, clinical scores). This avoids perverse outcomes where producers stop necessary treatment to hit targets. Allow exception pathways for high-risk outbreaks with veterinary justification and reporting.
British Poultry
+14) Scale up surveillance — pathogens, resistance, and antibiotic-use data (One Health).
Integrate AMR testing from clinical isolates, farm environments (litter, water), and slaughter/egg testing with antibiotic-use data to spot trends and emerging resistance early. Share summaries with public health and regulatory bodies.
Open Knowledge FAO
+15) Invest in prevention so antibiotics aren’t needed.
Prioritise proven non-pharmaceutical measures: vaccination programmes, robust biosecurity, improved housing/stocking density, nutrition and management (including humidity/ventilation), and targeted use of alternatives (probiotics, phytogenics, competitive exclusion). These reduce disease incidence and antibiotic demand.
PMC
+16) Rapid diagnostics and better record-keeping at flock level.
Support field-usable diagnostics and digital record systems so decisions are evidence-based (not empirical mass medication). Records enable audits, benchmarking and more precise stewardship.
QS
+17) Industry accountability: corporate procurement & retailer policies.
Retailers and integrators should require stewardship plans from suppliers (targets, reporting, veterinary oversight) and reward good performers — while giving technical support to lagging farms. Public retailer reports (like supermarket antibiotic reports) accelerate progress.
Tesco
+18) Communication & farmer/vet education.
Continuous training on AMR risks, appropriate drug choices, withdrawal times, and alternatives is vital. Frame stewardship as preserving both market access and bird health, not just regulatory burden.
PMCHow to avoid inadvertently causing an AMR or welfare crisis
Avoid blunt, year-end bans that remove therapeutic options without alternative disease control — phase changes with technical support.
Use outcome-based monitoring (mortality, disease incidence) alongside antibiotic metrics to ensure welfare isn’t compromised.
Maintain a clear, documented therapeutic pathway for emergencies that is audited afterwards.
Invest in environmental controls and waste management — reducing ARG spread in litter and runoff is critical.
PMC
+1-
Good 👍
-
Probiotic, Prebiotic, Synbiotic & postbiotic
-
I agree with you
-
shift from antibiotics to probiotics, prebiotics, phytogens
-
The poultry sector should prioritize strict antibiotic stewardship through preventive health programs, improved biosecurity, and vaccination instead of routine antibiotic use. Greater transparency in antibiotic reporting is essential to build public trust, while continuous monitoring and responsible prescription use can help control diseases without fueling antimicrobial resistance (AMR).
-
Great response. Thank you sir.
But, what actually cause resistant? I have been thinking on this for sometimes now. Could it be short administrative duration of the use the drug, under an ideal farm operation.
For instance, some antibiotics will say 5-7 days. Even, Lab usually recommends duration. If a farmer decided to use it for 4 days, all in the name of cutting cost.
What should a manager do in this case.
-
To ensure responsible antibiotic use in the poultry sector, a prudent strategy is to prioritize preventative measures like biosecurity, vaccination, and improved gut health, while drastically reducing or eliminating the use of antibiotics for growth promotion or preventive mass treatment. Greater public transparency and reporting on antibiotic use are crucial for building trust and tracking progress, and the industry can ensure this doesn’t lead to an AMR crisis by focusing on alternatives, adhering to strict stewardship guidelines, and implementing robust tracking and reporting systems.
-
👍👍 thanks
-
Good 💯
-
Log in to reply.
